+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected



Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected



Interactive Cardiovascular and Thoracic Surgery 21(1): 14-20



Despite recent progress in diagnostic technology and therapeutic approaches to non-small-cell lung cancer (NSCLC), 30-75% of patients develop tumour recurrence after resection. However, the details of post-recurrence survival (PRS) are not well understood. We aimed to investigate the predictors of PRS in patients with NSCLC initially completely resected. A series of 568 NSCLC patients who had undergone complete resection between 2000 and 2009 were evaluated retrospectively. Patients who had developed recurrent NSCLC after complete resection were subjected to the current analysis. We examined PRS using the Kaplan-Meier method and multivariate Cox regression analyses. Of the 568 patients, 138 (24.3%) were identified as having disease recurrence. The 2-year and 5-year PRS rates were 44.6 and 25.9%, respectively, while the median PRS time was 22.5 months. Non-adenocarcinoma histology [hazard ratio (HR) = 2.825, 95% confidence interval (CI): 1.825-4.367, P < 0.001], serum carcinoembryonic antigen (CEA) at recurrence ≥5.0 mg/dl (HR = 2.205, 95% CI: 1.453-3.344, P < 0.001) and no systemic chemotherapy (HR = 2.137, 95% CI: 1.304-3.247, P = 0.002) were independent prognostic factors for PRS. The current results showed that non-adenocarcinoma histology, elevated serum CEA at recurrence and no systemic chemotherapy were independent unfavourable post-recurrence prognostic factors. The current data can be informative for patient follow-up after complete resection and further clinical investigation may give us more information about PRS and accurate treatment strategy for recurrent NSCLC after initial complete resection.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058599969

Download citation: RISBibTeXText

PMID: 25878187

DOI: 10.1093/icvts/ivv085


Related references

P1.08-066 Prognostic Factors of Post-Recurrence Survival in Patients with Completely Resected Stage Iii-N2 Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 12(1): S771-S772, 2017

Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery 45(2): 262-267, 2014

Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery 54(3): 554-559, 2018

Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 64(3): 192-196, 2009

Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer. Journal of Thoracic Oncology 7(2): 397-405, 2012

Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer. Journal of Thoracic Oncology 7(7): 1115-1123, 2012

Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival. Journal of Thoracic and Cardiovascular Surgery 132(3): 499-506, 2006

Post-recurrence survival of elderly patients 75 years of age or older with surgically resected non-small cell lung cancer. Surgery Today 46(4): 430-436, 2016

The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival. Cancer Management and Research 5: 327-336, 2013

The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer. Lung Cancer 37(3): 303-309, 2002

Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer 34(1): 29-36, 2001

Prognostic factors in patients with postoperative brain recurrence from completely resected non-small cell lung cancer. Thoracic Cancer 6(1): 38-42, 2015

Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer. Annals of Surgical Oncology 21(8): 2546-2554, 2014

Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer. Journal of Thoracic Oncology 5(8): 1246-1250, 2010

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery 144(4): 794-807, 2012